4536.T
Price:
$1725
Market Cap:
$554.91B
Santen Pharmaceutical Co., Ltd. is a global enterprise engaged in the research, development, manufacturing, and marketing of both pharmaceutical products and medical devices. The company's primary focus lies in ophthalmic solutions, addressing a variety of eye conditions. Its pipeline for glaucoma and ocular hypertension includes several key assets: DE-111, currently in Phase III clinical trials; DE-117, available for sale in Japan; DE-126, progressing through Phase IIb trials; DE-128, which is on the market in Europe and undergoing Phase II/III trials in the United States; and DE-130A, also in Phase III development. Beyond glaucoma, Santen's offerings extend to other ocular ailments. It pro...[Read more]
Industry
Drug Manufacturers - General
IPO Date
2001-01-04
Stock Exchange
JPX
Ticker
4536.T
According to Santen Pharmaceutical Co., Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 2.82. This represents a change of 4.72% compared to the average of 2.69 of the last 4 quarters.
The mean historical Current Ratio of Santen Pharmaceutical Co., Ltd. over the last ten years is 2.75. The current 2.82 Current Ratio has changed 10.15% with respect to the historical average. Over the past ten years (40 quarters), 4536.T's Current Ratio was at its highest in in the December 2018 quarter at 3.88. The Current Ratio was at its lowest in in the March 2023 quarter at 2.38.
Average
2.75
Median
2.61
Minimum
2.38
Maximum
3.23
Discovering the peaks and valleys of Santen Pharmaceutical Co., Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 10.40%
Maximum Annual Current Ratio = 3.23
Minimum Annual Increase = -18.80%
Minimum Annual Current Ratio = 2.38
| Year | Current Ratio | Change |
|---|---|---|
| 2026 | 2.60 | 0.79% |
| 2025 | 2.58 | 1.50% |
| 2024 | 2.54 | 6.77% |
| 2023 | 2.38 | -0.46% |
| 2022 | 2.39 | -8.81% |
| 2021 | 2.63 | -18.80% |
| 2020 | 3.23 | 0.72% |
| 2019 | 3.21 | 8.90% |
| 2018 | 2.95 | 0.41% |
| 2017 | 2.94 | 10.40% |
The current Current Ratio of Santen Pharmaceutical Co., Ltd. (4536.T) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
2.58
5-year avg
2.50
10-year avg
2.75
Santen Pharmaceutical Co., Ltd.’s Current Ratio is greater than MediPal Holdings Corporation (1.29), greater than Sundrug Co.,Ltd. (1.83), greater than COSMOS Pharmaceutical Corporation (0.77), greater than Suzuken Co., Ltd. (1.22), greater than Sugi Holdings Co.,Ltd. (1.42), greater than Alfresa Holdings Corporation (1.21), less than Hisamitsu Pharmaceutical Co., Inc. (4.08), greater than Toho Holdings Co., Ltd. (1.25), less than Kissei Pharmaceutical Co., Ltd. (6.03), greater than Kusuri No Aoki Holdings Co., Ltd. (1.32),
| Company | Current Ratio | Market cap |
|---|---|---|
| 1.29 | $590.76B | |
| 1.83 | $428.74B | |
| 0.77 | $515.25B | |
| 1.22 | $349.89B | |
| 1.42 | $470.35B | |
| 1.21 | $402.57B | |
| 4.08 | $425.23B | |
| 1.25 | $254.92B | |
| 6.03 | $165.39B | |
| 1.32 | $379.85B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Santen Pharmaceutical Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Santen Pharmaceutical Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Santen Pharmaceutical Co., Ltd.'s Current Ratio?
How is the Current Ratio calculated for Santen Pharmaceutical Co., Ltd. (4536.T)?
What is the highest Current Ratio for Santen Pharmaceutical Co., Ltd. (4536.T)?
What is the 3-year average Current Ratio for Santen Pharmaceutical Co., Ltd. (4536.T)?
What is the 5-year average Current Ratio for Santen Pharmaceutical Co., Ltd. (4536.T)?
How does the current Current Ratio for Santen Pharmaceutical Co., Ltd. (4536.T) compare to its historical average?